Thyroid hormone receptor β1 in normal colon and colorectal cancer-association with differentiation, polypoid growth type and K-ras mutations

International Journal of Cancer

Volumn 118, Issue 7, 2006, Pages 1653-1659

  Hörkkö, Tuomo T ^a   Tuppurainen, Karoliina ^a   George, Susannah M ^a   Jernvall, Petra ^a   Karttunen, Tuomo J ^a   Mäkinen, Markus J ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

Colorectal cancer classification; K ras oncogene; Thyroid hormone receptors beta

Indexed keywords

THYROID HORMONE; THYROID HORMONE RECEPTOR BETA; THYROID HORMONE RECEPTOR BETA1; UNCLASSIFIED DRUG;

ADENOMA; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CELL DIFFERENTIATION; CELL NUCLEUS; CELL PROLIFERATION; COLON MUCOSA; COLORECTAL CANCER; CYTOPLASM; FEMALE; GENE MUTATION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; ONCOGENE K RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ADENOCARCINOMA; ADENOMA; ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; COLORECTAL NEOPLASMS; FEMALE; GENES, RAS; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MALE; MIDDLE AGED; MUTATION; SIGNAL TRANSDUCTION; THYROID HORMONE RECEPTORS BETA;

EID: 33644850678     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.21556     Document Type: Article

References (48)

1. Chiang JM, Chou YH, Chou TB. K-ras codon 12 mutation determines the polypoid growth of colorectal cancer. Cancer Res 1998; 58:3289-93.
2. Hasegawa H, Ueda M, Watanabe M, Teramoto T, Mukai M, Kitajima M. K-ras gene mutations in early colorectal cancer ... flat elevated vs polyp-forming cancer. Oncogene 1995;10:1413-6.
3. Kobayashi M, Watanabe H, Ajioka Y, Honma T, Asakura H. Effect of K-ras mutation on morphogenesis of colorectal adenomas and early cancers: relationship to distribution of proliferating cells. Hum Pathol 1996;27:1042-9.
4. Oppenheimer JH. The molecular basis of thyroid hormone action: scattered pieces of jigsaw puzzle. Prog Clin Biol Res 1981;74:45-55.
5. Kohrle J. Thyroid hormone metabolism and action in the brain and pituitary. Acta Med Austriaca 2000;27:1-7.
6. Lin KH, Lin YW, Parkison C, Cheng SY. Stimulation of proliferation by 3,3′,5-triiodo-L-thyronine in poorly differentiated human hepatocarcinoma cells overexpressing β1 thyroid hormone receptor. Cancer Lett 1994;85:189-94.
7. Toms SA, Hercbergs A, Liu J, Kondo S, Barnett GH, Casey G, Barna BP. Thyroid hormone depletion inhibits astrocytoma proliferation via a p53-independent induction of p21 (WAF1/CIP1). Anticancer Res 1998;18:289-93.
8. Bartunek P, Zenke M. Retinoid X receptor and c-cerbA/thyroid hormone receptor regulate erythroid cell growth and differentiation. Mol Endocrinol 1998;12:1269-79.
9. Bauer A, Mikulits W, Lagger G, Stengl G, Brosch G, Beug H. The thyroid hormone receptor functions as a ligand-operated developmental switch between proliferation and differentiation of erythroid progenitors. EMBO J 1998;17:4291-303.
10. Mihara S, Suzuki N, Wakisaka S, Suzuki S, Sekita N, Yamamoto S, Saito N, Hoshino T, Sakane T. Effects of thyroid hormones on apoptotic cell death of human lymphocytes. J Clin Endocrinol Metab 1999;84:1378-85.
11. Llanos S, Caelles C, Azorin I, Renau-Piqueras J, Fernandez-Luna JL, Bosca L, Munoz A. The c-erbA α protooncogene induces apoptosis in glial cells via a protein kinase C- and bcl-2-suppressible mechanism. J Neurochem 1998;70:2315-26.
12. Plateroti M, Chassande O, Fraichard A, Gauthier K, Freund JN, Samarut J, Kedinger M. Involvement of T3R α and β receptor subtypes in mediation of T3 functions during postnatal murine intestinal development. Gastroenterology 1999;116:1367-78.
13. Shibusawa N, Hashimoto K, Nikrodhanond AA, Liberman MC, Applebury ML, Liao XH, Robbins JT, Refetoff S, Cohen RN, Wondisford FE. Thyroid hormone action in the absence of thyroid hormone receptor DNA-binding in vivo. J Clin Invest 2003;112: 588-97.
14. Cheng Sy S. New insights into the structure and function of the thyroid hormone receptor. J Biomed Sci 1995;2:77-89.
15. Williams GR. Cloning and characterization of two novel thyroid hormone receptor β isoforms. Mol Cell Biol 2000;20:8329-42.
16. Bradley DJ, Towle HC, Young WS, III. Spatial and temporal expression of α and β thyroid hormone receptor mRNAs, including the β-2 subtype, in the developing mammalian nervous system. J Neurosci 1992;12:2288-302.
17. Lazar MA. Thyroid hormone receptors: multiple forms, multiple possibilities. Endocr Rev 1993;14:184-93.
18. Tagami T, Nakamura H, Sasaki S, Miyoshi Y, Imura H. Estimation of the protein content of thyroid hormone receptor α-1 and β-1 in rat tissues by Western blotting. Endocrinology 1993;132:275-9.
19. Yen PM, Chin WW. New advances in understanding the molecular mechanisms of the thyroid hormone action. Trends Endocrinol Metab 1994;5:65-72.
20. Rastinejad F, Perlmann T, Evans RM, Sigler PB. Structural determinants of nuclear receptor assembly on DNA direct repeats. Nature 1995:375:203-11.
21. Horlein AJ, Naar AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Soderstrom M, Glass CK, Rosenfeld MG. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 1995;377:397-404.
22. Chen JD, Evans RM. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 1995;377:454-7.
23. Onate SA, Tsai SY, Tsai MJ, O'Malley BW. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 1995;270:1354-7.
24. Takeshita A, Yen PM, Misiti S, Cardona GR, Liu Y, Chin WW. Molecular cloning and properties of a full-length putative thyroid hormone receptor coactivator. Endocrinology 1996;137:3594-7.
25. Yap N, Yu CL, Cheng SY. Modulation of the transcriptional activity of thyroid hormone receptors by the tumor suppressor p53. Proc Natl Acad Sci USA 1996;93:4273-7.
26. Lin KH, Lin YW, Lee HF, Liu WL, Chen ST, Chang KS, Cheng SY. Increased invasive activity of human hepatocellular carcinoma cells is associated with an overexpression of thyroid hormone β-1 nuclear receptor and low expression of the anti-metastatic nm23 gene. Cancer Lett 1995;98:89-95.
27. Williams GR, Bland R, Sheppard MC. Characterization of thyroid hormone (T3) receptors in three osteosarcoma cell lines of distinct osteoblast phenotype: interactions among T3, vitamin D3, and retinoid signaling. Endocrinology 1994;135:2375-85.
28. Puzianowska-Kuznicka M, Nauman A, Madej A, Tanski Z, Cheng S, Nauman J. Expression of thyroid hormone receptors is disturbed in human renal clear cell carcinoma. Cancer Lett 2000;155:145-52.
29. Garcia-Silva S, Aranda A. The thyroid hormone receptor is a suppressor of ras-mediated transcription, proliferation, and transformation. Mol Cell Biol 2004;24:7514-23.
30. George SM, Mäkinen MJ, Jernvall P, Mäkelä J, Vihko P, Karttunen TJ. Classification of advanced colorectal carcinomas by tumor edge morphology: evidence for different pathogenesis and significance of polypoid and nonpolypoid tumors. Cancer 2000;89:1901-9.
31. Mäkinen MJ, George SM, Jernvall P, Mäkelä J, Vihko P, Karttunen TJ. Colorectal carcinoma associated with serrated adenoma-prevalence, histological features, and prognosis. J Pathol 2001;193:286-94.
32. Jernvall P, Mäkinen M, Karttunen TJ, Mäkelä J, Vihko P. Conserved region mutations of the p53 gene are concentrated in distal colorectal cancers. Int J Cancer 1997;74:97-101.
33. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
34. Jernvall P, Mäkinen MJ, Karttunen TJ, Mäkelä J, Vihko P. Loss of heterozygosity at 18q21 is indicative of recurrence and therefore poor prognosis in a subset of colorectal cancers. Br J Cancer 1999; 79:903-8.
35. Lin KH, Willingham MC, Liang CM, Cheng SY. Intracellular distribution of the endogenous and transfected β form of thyroid hormone nuclear receptor visualized by the use of domain-specific monoclonal antibodies. Endocrinology 1991;128:2601-9.
36. Baumann CT, Maruvada P, Hager GL, Yen PM. Nuclear cytoplasmic shuttling by thyroid hormone receptors, multiple protein interactions are required for nuclear retention. J Biol Chem 2001;276: 11237-45.
37. Zhu XG, Hanover JA, Hager GL, Cheng SY. Hormone-induced translocation of thyroid hormone receptors in living cells visualized using a receptor green fluorescent protein chimera. J Biol Chem 1998;273: 27058-63.
38. Damm K, Thompson CC, Evans RM. Protein encoded by v-erbA functions as a thyroid-hormone receptor antagonist. Nature 1989;339:593-7.
39. Lebel JM, Dussault JH, Puymirat J. Overexpression of the β-1 thyroid receptor induces differentiation in neuro-2a cells. Proc Natl Acad Sci USA 1994;91:2644-8.
40. Maruvada P, Baumann CT, Hager GL, Yen PM. Dynamic shuttling and intranuclear mobility of nuclear hormone receptors. J Biol Chem 2003;278:12425-32.
41. Kamiya Y, Puzianowska-Kuznicka M, McPhie P, Nauman J, Cheng SY, Nauman A. Expression of mutant thyroid hormone nuclear receptors is associated with human renal clear cell carcinoma. Carcinogenesis 2002;23:25-33.
42. Lin KH, Shieh HY, Chen SL, Hsu HC. Expression of mutant thyroid hormone nuclear receptors in human hepatocellular carcinoma cells. Mol Carcinog 1999;26:53-61.
43. Lin KH, Shieh HY, Hsu HC. Negative regulation of the antimetastatic gene Nm23-H1 by thyroid hormone receptors. Endocrinology 2000; 141:2540-7.
44. Li Z, Meng ZH, Chandrasekaran R, Kuo WL, Collins CC, Gray JW, Dairkee SH. Biallelic inactivation of the thyroid hormone receptor β-1 gene in early stage breast cancer. Cancer Res 2002;62:1939-43.
45. Bhat MK, Yu C, Yap N, Zhan Q, Hayashi Y, Seth P, Cheng S. Tumor suppressor p53 is a negative regulator in thyroid hormone receptor signaling pathways. J Biol Chem 1997;272:28989-93.
46. Cawkwell L, Quirke P. The molecular biology and genetics of colorectal cancer. In: Williams NS, ed. Colorectal cancer. London: Churchill Livingstone, 1996.1p.
47. Horkko TT, Makinen MJ. Colorectal proliferation and apoptosis in serrated versus conventional adenoma-carcinoma pathway: growth, progression and survival. Scand J Gastroenterol 2003;38:1241-8.
48. Yashiro M, Carethers JM, Laghi L, Saito K, Slezak P, Jaramillo E, Rubio C, Koizumi K, Hirakawa K, Boland CR. Genetic pathways in the evolution of morphologically distinct colorectal neoplasms. Cancer Res 2001;61:2676-83.